For COVID-19 vaccines, the determination of the atomic structure of S protein subunits using structural vaccinology tools enabled researchers to generate pre-fusion stabilised SARS-CoV-2 protein, which is more stable and expressed at a higher level in comparison to the wild-type soluble S protein [21]. The gene discussed is PROS1; the disease is COVID-19.